澳洲幸运10开奖官网：开奖结果直播+168澳洲10开奖历史号码查询 Bavarian Nordic preps chikungunya vaccine filings
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
Biotech investment in UK ticks up in Q2
Despite the economic downturn, UK life sciences companies raised a healthy £382 million ($486 million) in new financing in the second quarter of the year, with venture cap
UK opens '100-day' rapid-response vaccine unit
The UK government has formally opened a state-of-the-art vaccine research facility based at the UK Health and Security Agency (UKHSA) to improve the country's preparedness
澳洲幸运10官网开奖结果直播|168澳洲10开奖历史查询、在线开奖官网计划 Open-source technology – the next step in pharmaceutical evo...
Open-source technology is an increasingly popular topic of conversation in the business world, with forward-thinking entrepreneurs around the globe recognising it as a solution set to expon
Astellas' Iveric takeover rewarded with FDA nod for GA drug
The FDA has approved a new drug for sight-robbing disease geographic atrophy from Astellas, just a few weeks after the company
Featured Content 2023澳洲幸运10官网开奖直播、查询幸运澳洲10开奖结果
Editor's Picks 2023澳洲幸运10官网开奖直播、查询幸运澳洲10开奖结果 历史号码查询
Editor's Picks 2023澳洲幸运10官网开奖直播、查询幸运澳洲10开奖结果 历史号码查询
Latest News 澳洲幸运10开奖官网 查询幸运澳洲10开奖结果+168澳洲幸运10在线开奖官网计划
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
8c10.jpg)
Mastering Engagement: How Do AI and ML Drive Pharma's Omnich...
Many articles on artificial intelligence (AI) promise amazing results, tons of money, and thousands of new clients, all thanks to the magical tool.
Rare Conditions and the Need for Support & Connection
Among various challenges, living with a rare condition can be quite lonely.
How to Use a Content Experience Platform in Pharma
Every marketer and sales representative shares a common desire: to achieve more with less effort.
The Critical Importance of Community KOLs
The top global KOLs in a therapy area might offer some insight into HCP behaviour in their geographies, but to understand the national and local challenges in a target region, you’ll need c
2nd Lipid Nanoparticle Development Europe Summit
Expedite LNP Applications for Next Generation Therapeutics beyond mRNA with Optimised Formulation, Scalability & Regulatory Compliance at Forefront of Mind